Phillips-Medisize, LLC

Phillips-Medisize is a contract development and manufacturing organization (CDMO) specializing in design and manufacturing services for pharmaceutical, medtech, and in vitro diagnostic companies. With operations across the US, Europe, and Asia, the company provides end-to-end product development from discovery through commercial delivery. Core capabilities include advanced manufacturing technologies such as injection molding, precision assembly, and automated manufacturing with mixed reality and AI integration. The company serves multiple market segments including respiratory drug delivery devices, cardiac catheterization systems (including pulsed field ablation technology), medical connectors, and diagnostic reagent handling systems. Phillips-Medisize maintains regulatory compliance across FDA, ISO, and international standards, supporting clients in bringing complex medical devices and pharmaceutical delivery systems to market. The company emphasizes personalized customer engagement, engineering excellence, and quality assurance throughout the manufacturing lifecycle. Recent focus areas include next-generation cardiac ablation technologies and automation in medical device assembly.